Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Morgenthaler
AddedFeb 13, 2024
UpdatedJun 28, 2026
Morgenthaler

Morgenthaler

Operating

Morgenthaler Ventures: A US-based private equity firm investing in healthcare, tech, and life sciences.

Location
Menlo Park, CA, US
Founded
1968
Firm
Compare
Portfolio
Employees

Investments

Relievant Medsystems
Relievant Medsystems
Public

Total Raised

$273.6M

Rounds

9

Series G$50MMarch 2023
Series Unknown$70MOctober 2020
Series D$36MOctober 2016
Setpoint Medical
Setpoint Medical

Total Raised

$344M

Rounds

12

Series Unknown$80MJanuary 2023
Series Unknown$64MJanuary 2021
Series Unknown$15.7MSeptember 2019
Series D$30MAugust 2017
Series C$15MSeptember 2015
Moximed
Moximed
Public

Total Raised

$183.2M

Rounds

8

Series C$40MAugust 2022
Series C$50MMarch 2017
Series B$33MMay 2015
Nuvaira
Nuvaira

Total Raised

$204M

Rounds

10

Series E$79MFebruary 2019
Series D$42MApril 2014
Vapotherm
Vapotherm
Public

Total Raised

$276.6M

Rounds

14

Series D$10MSeptember 2018
Series D$45MMay 2017
Series C$30MNovember 2015
Series C$20MJuly 2015
Series B$24MApril 2014
Second Genome
Second Genome
Acquired

Total Raised

$62.5M

Rounds

4

Series B$51MApril 2016
Elcelyx Therapeutics
Elcelyx Therapeutics

Total Raised

$96.8M

Rounds

6

Series E$40MOctober 2015
Series C$24.7MFebruary 2014
Galleon Pharmaceuticals
Galleon Pharmaceuticals
Acquired

Total Raised

$53M

Rounds

8

Series B$10MJune 2015
Sunlight Aerospace
Sunlight Aerospace

Total Raised

$9.4M

Rounds

2

Series Unknown$8.4MDecember 2014
Forsight Labs
Forsight Labs

Total Raised

$69.4M

Rounds

11

Series C$15MApril 2014
Calithera Biosciences
Calithera Biosciences
Public

Total Raised

$341.4M

Rounds

13

Series D$35MOctober 2013